BRPI0511077A - 7-t-butoximinometilcamptotecina conjugada na posição 20 com antagonistas de integrina - Google Patents

7-t-butoximinometilcamptotecina conjugada na posição 20 com antagonistas de integrina

Info

Publication number
BRPI0511077A
BRPI0511077A BRPI0511077-7A BRPI0511077A BRPI0511077A BR PI0511077 A BRPI0511077 A BR PI0511077A BR PI0511077 A BRPI0511077 A BR PI0511077A BR PI0511077 A BRPI0511077 A BR PI0511077A
Authority
BR
Brazil
Prior art keywords
butoxyiminomethylcamptothecin
conjugated
integrin antagonists
compounds
antagonists
Prior art date
Application number
BRPI0511077-7A
Other languages
English (en)
Inventor
Alma Dal Pozzo
Sergio Penco
Lucio Merlini
Giuseppe Giannini
Maria Ornella Tinti
Claudio Pisano
Franco Zunino
Domenico Alloatti
Loredana Vesci
Sabrina Dallavalle
Ming Hong Ni
Original Assignee
Sigma Tau Ind Farmaceuti
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Ist Naz Stud Cura Dei Tumori filed Critical Sigma Tau Ind Farmaceuti
Publication of BRPI0511077A publication Critical patent/BRPI0511077A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

7-T-BUTOXIMINOMETILCAMPTOTECINA CONJUGADA NA POSIçãO 20 COM ANTAGONISTAS DE INTEGRINA. A presente invenção refere-se a compostos de Fórmula (1), no qual o grupo R~ 1~ é como definido na especificação e inclui a condensação de 7-t-butoximinometilcamptotecina na posição 20 com um ciclopeptídeo contendo a seqüência RGD. Os ditos compostos são dotados tanto com alta afinidade para os receptores de integrina <244>~ v~<225>~ 3~ e <244>~ v~<225>5, e com atividade citotóxica seletiva em linhas de células de tumor humano a concentrações micro-moleculares.
BRPI0511077-7A 2004-05-13 2005-04-28 7-t-butoximinometilcamptotecina conjugada na posição 20 com antagonistas de integrina BRPI0511077A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000242A ITRM20040242A1 (it) 2004-05-13 2004-05-13 "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
PCT/IT2005/000245 WO2005110486A2 (en) 2004-05-13 2005-04-28 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists

Publications (1)

Publication Number Publication Date
BRPI0511077A true BRPI0511077A (pt) 2007-12-26

Family

ID=35124315

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511077-7A BRPI0511077A (pt) 2004-05-13 2005-04-28 7-t-butoximinometilcamptotecina conjugada na posição 20 com antagonistas de integrina

Country Status (12)

Country Link
US (1) US7589099B2 (pt)
EP (1) EP1747020A2 (pt)
JP (1) JP2007537243A (pt)
CN (1) CN101065150A (pt)
AR (1) AR049337A1 (pt)
AU (1) AU2005243883A1 (pt)
BR (1) BRPI0511077A (pt)
CA (1) CA2562569A1 (pt)
IT (1) ITRM20040242A1 (pt)
MX (1) MXPA06012885A (pt)
TW (1) TW200538123A (pt)
WO (1) WO2005110486A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040239A1 (it) * 2004-05-13 2004-08-13 Sigma Tau Ind Farmaceuti Derivati ciclopeptidici ad attivita' antintegrine.
WO2011086553A1 (en) * 2010-01-13 2011-07-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Cyclic peptides, compositions comprising them and uses thereof as nucleases of nucleotidic macromolecules
CN103275094B (zh) * 2013-05-08 2015-07-08 中国农业科学院植物保护研究所 (20s)-喜树碱的衍生物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19815812A1 (de) * 1998-04-08 1999-10-14 Bayer Ag Modifizierte Cytostatika
ATE216998T1 (de) * 1999-03-09 2002-05-15 Sigma Tau Ind Farmaceuti Camptothecin-derivate mit antitumor-wirkung
ITRM20020306A1 (it) * 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Esteri in posizione 20 di camptotecine.

Also Published As

Publication number Publication date
EP1747020A2 (en) 2007-01-31
CN101065150A (zh) 2007-10-31
AR049337A1 (es) 2006-07-19
US20070225311A1 (en) 2007-09-27
AU2005243883A1 (en) 2005-11-24
WO2005110486A3 (en) 2007-03-08
US7589099B2 (en) 2009-09-15
ITRM20040242A1 (it) 2004-08-13
MXPA06012885A (es) 2007-08-14
CA2562569A1 (en) 2005-11-24
JP2007537243A (ja) 2007-12-20
WO2005110486A2 (en) 2005-11-24
TW200538123A (en) 2005-12-01

Similar Documents

Publication Publication Date Title
BRPI0510983A (pt) camptotecinas conjugadas na posição 7 a peptìdeos cìclicos como agentes citoestáticos
BRPI0417771A (pt) heterociclos azabicìclicos como moduladores de receptor canabinóides
BRPI0409960A (pt) derivados de oxima de hidróxi-bifenil-carbaldeìdo e seu uso como agentes estrogênicos
BR0009320A (pt) Dibenzopiranos como antagonistas do receptor glicocorticóide para o tratamento da diabete
BRPI0410418A (pt) fenil quinolinas e seu uso como moduladores do receptor de estrogênio
BRPI0613005A8 (pt) uso de polipeptídeos de aprotinina como veículos em conjugados farmacêuticos.
BR0112582A (pt) Sulfonamidas de ciclilamina como agonistas de receptores beta-3 adrenérgicos
BR0214666A (pt) Derivados de acetileno tendo atividade antagonìstica de mglur5
BRPI0412314A (pt) derivados de pirimidina-2,4-diona como antagonistas de receptor de hormÈnio liberador de gonadotropina
BRPI0510736A (pt) compostos de amido e seu uso como produtos farmacêuticos
UY28855A1 (es) Derivados de la 1-amino-ftalazina su preparación y su uso en terapia
BR0313197A (pt) Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico
BR0214767A (pt) Benzoxazóis substituìdos e análogos como agentes estrogênicos
BRPI0410645A (pt) derivados de aril-carbaldeìdo oxima e sua aplicação como agentes estrogênicos
BRPI0111220B1 (pt) conjugados de fármacos com etilenodicisteína (ec)
BR0110079A (pt) Combinação de compostos orgânicos
BRPI0818193B8 (pt) composto, composição farmacêutica, e, uso de um composto
BG66085B1 (bg) Фенилаланинови производни
BRPI0821266B8 (pt) Derivados de arilamida triazol-substituída e seu uso e composição farmacêutica
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
SV2008002986A (es) Moduladores de indol sulfonamida de receptores de progesterona ref. x-17207
ECSP099177A (es) Derivados de quinazolinona e isoquinolinona
BRPI0518607A2 (pt) derivados de pirrol tendo atividade antagonista de receptor crth2
BRPI0512376A (pt) piperazinodionas como antagonistas de receptor oxitocina
BRPI0515983A (pt) antagonistas não peptìdicos da bradicinina, composições farmacêuticas compreendendo os mesmos e uso

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.

B15K Others concerning applications: alteration of classification

Ipc: A61K 47/64 (2017.01), A61P 35/00 (2006.01), A61P 3